Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Ground Breaking Pill found to ‘kill Tumours’
View:
Post by markpun on Aug 02, 2023 3:54am

Ground Breaking Pill found to ‘kill Tumours’

Comment by Oilminerdeluxe on Aug 02, 2023 5:20am
I was just going to post it. On the news this morning. Interesting
Comment by 99942Apophis on Aug 02, 2023 8:58am
They didn't discuss results of their animal testing,  perhaps when they complete their Phase 1 human study we will know how effective it is. Still very interesting, this pill must go through the cycle of clinical study and I can assume full disclosure on adverse affects to patients along with CR percentages.  Looks like Theralase might have some competition in 10 years
Comment by Alamir1111 on Aug 02, 2023 11:19am
A pill to kill cancer What else is going to damage. Sweet dreams
Comment by Alamir1111 on Aug 02, 2023 11:22am
Tik tok claims Borox kills cancer too
Comment by Alamir1111 on Aug 02, 2023 11:25am
Sorry posters on tik tok
Comment by gojotv! on Aug 02, 2023 9:15pm
I heard about it this morning, as it was all over the British news, TV and papers... Gotta say one thing about this pill, whoever's in charge of the PR is doing a bang-up job of it. International attention in just one day... !
Comment by Alamir1111 on Aug 02, 2023 8:15am
Every other week there is a new discovery that claims they kill or treat cancer.
Comment by stocksnbonds458 on Aug 04, 2023 5:44pm
Yeah, I read that one. These "miracle cure all" drugs fail 100% of the time regardless of how promising they are initially. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250